Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

BACKGROUND: Rasagiline is a monoamine oxidase-B inhibitor used for Parkinson’s disease (PD) treatment, but its effectiveness on Chinese patients is unclear. This study aimed to evaluate the efficacy and safety of rasagiline monotherapy in Chinese patients with early PD. METHODS: A 26-weeks, randomiz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Neurodegener
Main Authors: Zhang, Zhenxin, Wang, Jian, Chen, Shengdi, Liu, Chunfeng, Zhang, Baorong, Peng, Rong, Sun, Shenggang, Sun, Xiangru, Zhao, Gang, Qu, Qiumin, Li, Yansheng, Zhu, Suiqiang, Pan, Xiaoping, Shao, Ming, Wang, Yanping
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282325/
https://ncbi.nlm.nih.gov/pubmed/30534374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-018-0137-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados